Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Exosome Research Market by Offering (Kits, Reagents (Antibodies, Isolation, Purification), Instruments, Services), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem Cell) - Global Forecast to 2030
... market is primarily fueled by the escalating incidence of chronic diseases, including cancer, neurodegenerative disorders, and CVDs; this trend underscores the urgent need for novel diagnostic and therapeutic strategies. Exosomes, due to their properties as ... Read More
-
Breast Tissue Markers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... biopsies and surgeries, ensuring accurate diagnosis and targeted treatment of breast cancer. According to market analysis, the global breast tissue markers market is expected to grow from US$ 3.3 billion in 2025 to US$ 6.1 ... Read More
-
Breast Recurrence Score Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... rate (CAGR) of 10.00% during the forecast period. Rising global breast cancer incidence, technological progress in genomic profiling, and the increasing preference for non-invasive diagnostic methods are driving the market forward. Market Insights Breast recurrence ... Read More
-
Global & Vietnam Cancer Therapeutics Market to 2031
... access to cancer care services. The Vietnamese Ministry of Health has teamed up with global pharma companies to increase the availability of oncology drugs within public healthcare facilities. These efforts have helped bring innovative cancer ... Read More
-
Global & New Zealand Cancer Therapeutics Market to 2031
... and death, with lung, breast, prostate, and colorectal cancers being the most prevalent. The incidence of cancer has steadily grown in recent years, driven by factors such as an aging population, lifestyle changes, and environmental ... Read More
-
Global & Argentina Cancer Therapeutics Market to 2031
... to The Global Cancer Observatory, Argentina recorded approximately 130,000 new cases and around 70,000 cancer-related deaths in 2020. The country sees high rates of cervical, colorectal, and breast cancers, with GLOBOCAN 2020 reporting nearly 15,895 ... Read More
-
Global & Algeria Cancer Therapeutics Market to 2031
... to treatment and improve patient outcomes by strengthening its healthcare infrastructure and introducing more advanced therapies. Acknowledging the urgency of addressing this public health challenge, the Algerian government—through the Ministry of Health—has implemented several measures ... Read More
-
Global & Bangladesh Cancer Therapeutics Market to 2031
... producing generic cancer medications, which helps make treatments more affordable and accessible to a larger segment of patients. However, the market faces challenges including the absence of widespread cancer screening programs, limited availability of advanced ... Read More
-
Global & Chile Cancer Therapeutics Market to 2031
... and Social Affairs reported that in 2019, around 11.5% of Chile's population was aged 65 or older, and this figure is projected to rise to 21% by 2041. Chile’s public health insurer, FONASA, currently provides ... Read More
-
Global & Colombia Cancer Therapeutics Market to 2031
... including chemotherapy and targeted therapies, to manage various cancer types such as breast cancer. In response, the Colombian government has implemented several measures to enhance cancer care and improve patient access to therapies. The National ... Read More
-
Global & Czech Republic Cancer Therapeutics Market to 2031
... contributing to this increase include high alcohol consumption and a growing obese population. The government plays a crucial role in cancer management through the maintenance of the National Oncological Register (NOR), which helps track and ... Read More
-
Global & France Cancer Therapeutics Market to 2031
... of individuals aged 85 and older is projected to increase by nearly 90% between 2030 and 2050. This growing elderly population is a significant factor contributing to the expansion of the cancer therapeutics market, as ... Read More
-
Global & Egypt Cancer Therapeutics Market to 2031
... of newly diagnosed cases continuing to climb. According to GLOBOCAN 2020 data, Egypt recorded approximately 134,632 new cancer cases and 89,042 deaths related to cancer that year. This growing health challenge has fueled demand for ... Read More
-
Global & Malaysia Cancer Therapeutics Market to 2031
... improve patient survival rates, the Ministry of Health established the National Cancer Control Blueprint. Data from the National Cancer Registry (NCR) indicates that approximately 50,000 new cancer cases are diagnosed annually in Malaysia, with breast, ... Read More
-
Global & Mexico Cancer Therapeutics Market to 2031
... cases were recorded in Mexico in 2022. Among these, breast cancer was the most prevalent, accounting for 15% of all diagnoses, followed by prostate cancer. The rising incidence of cancer is fueling demand for advanced ... Read More
-
Global & Portugal Cancer Therapeutics Market to 2031
... driving the demand for more advanced and effective treatment options. As the number of patients continues to grow, the cancer therapeutics market is expanding, with healthcare providers striving to improve access to life-saving therapies and ... Read More
-
Global & Spain Cancer Therapeutics Market to 2031
... demand for effective cancer therapies and improved patient care. The Spanish government actively promotes cancer awareness, supports innovation, and works to enhance access to advanced, life-saving treatments. On May 6, 2024, the European Cancer Organisation ... Read More
-
Global & Saudi Arabia Cancer Therapeutics Market to 2031
... related mortality rates. According to GLOBOCAN 2020, approximately 27,885 new cancer cases were reported, with projections indicating a rise to 60,429 cases by 2040. The report Rights and Wellbeing of Older Persons in Saudi Arabia ... Read More
-
Global & Switzerland Cancer Therapeutics Market to 2031
... equating to roughly 377 cases per 100,000 people. The high incidence of cancer highlights the urgent need for effective treatment options in the country. In 2018, Switzerland joined forces with Australia, Canada, and Singapore to ... Read More
-
Global & Greece Cancer Therapeutics Market to 2031
... reported in 2022, with the disease causing more than 32,000 deaths. Among men, prostate, lung, and colorectal cancers are the most commonly diagnosed, while breast cancer leads among women, followed by colorectal and lung cancers. ... Read More
-
Global & Finland Cancer Therapeutics Market to 2031
... men; colorectal cancer affected both genders significantly. This rising cancer incidence has driven increased demand for innovative and effective treatment options. Leading research institutions such as the University of Helsinki, the Finnish Institute for Molecular ... Read More
-
Global & Luxembourg Cancer Therapeutics Market to 2031
... all yearly fatalities in the country. Luxembourg has become a key player in global cancer research and oncology, demonstrated by its substantial investment in research infrastructure, international collaborations, and development of scientific expertise. The nation ... Read More
-
Global & Norway Cancer Therapeutics Market to 2031
... In 2023, the Norwegian Cancer Society allocated approximately US$ 6.67 million (NOK 71 million) to researchers at the Faculty of Medicine (MED), highlighting its commitment to advancing cancer research in the country. Further reinforcing these ... Read More
-
Global & South Korea Cancer Therapeutics Market to 2031
... approximately 274,488 new cancer cases that year. Thyroid cancer topped the list as the most frequently diagnosed, followed by lung, colorectal, breast, and stomach cancers. This growing cancer burden is fueling a corresponding surge in ... Read More
-
Global & Turkey Cancer Therapeutics Market to 2031
... including immunotherapy and targeted therapies. In response, the Turkish government has launched several initiatives to enhance the development and accessibility of such treatments. One key effort is the Ministry of Health's National Cancer Control Program, ... Read More
Research Assistance
